CTXR 3.37 +15%. cash/ share around $4.8 (About $35m cash, financing completed, raised $27m recently) vs only $22m marker cap. w/ near term Catalysts for both Phase 2 and Phase 3.
CTXR up 10% on Friday. Way undervalued.
Lead product (Mino-Lok)..has been granted QIDP, and is in Phase 3. There is no approved competition nor any on the horizon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.